{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Osthole", "cognitive disorder", "network proximity", "neuroinflammation", "neuronal apoptosis"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38202603", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "12"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "12"}, "Article": {"Language": ["eng"], "ELocationID": ["21", "10.3390/molecules29010021"], "ArticleDate": [{"Year": "2023", "Month": "12", "Day": "19"}], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "29", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Dec", "Day": "19"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Network Proximity Analysis Deciphers the Pharmacological Mechanism of Osthole against D-Galactose Induced Cognitive Disorder in Rats.", "Abstract": {"AbstractText": ["Osthole, a natural coumarin found in various medicinal plants, has been previously reported to have neuroprotective effects. However, the specific mechanism by which Osthole alleviates dysmnesia associated with Alzheimer's disease (AD) remains unclear. This study aimed to investigate the neuroprotective properties of Osthole against cognitive impairment in rats induced by D-galactose and elucidate its pharmacological mechanism. The rat model was established by subcutaneously injecting D-galactose at a dose of 150 mg/kg/day for 56 days. The effect of Osthole on cognitive impairment was evaluated by behavior and biochemical analysis. Subsequently, a combination of in silico prediction and experimental validation was performed to verify the network-based predictions, using western blot, Nissl staining, and immunofluorescence. The results demonstrate that Osthole could improve memory dysfunction induced by D-galactose in Sprague Dawley male rats. A network proximity-based approach and integrated pathways analysis highlight two key AD-related pathological processes that may be regulated by Osthole, including neuronal apoptosis, i.e., neuroinflammation. Among them, the pro-apoptotic markers (Bax), anti-apoptotic protein (Bcl-2), the microgliosis (Iba-1), Astro-cytosis (GFAP), and inflammatory cytokines (TNF-R1) were evaluated in both hippocampus and cortex. The results indicated that Osthole significantly ameliorated neuronal apoptosis and neuroinflammation in D-galactose-induced cognitive impairment rats. In conclusion, this study sheds light on the pharmacological mechanism of Osthole in mitigating D-galactose-induced memory impairment and identifies Osthole as a potential drug candidate for AD treatment, targeting multiple signaling pathways through network proximity and integrated pathways analysis."]}, "AuthorList": [{"Identifier": ["0000-0001-6521-1333"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China."}], "LastName": "Wang", "ForeName": "Xue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China."}], "LastName": "Fu", "ForeName": "Xiaomei", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China."}], "LastName": "Luo", "ForeName": "Xiurong", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China."}], "LastName": "Lai", "ForeName": "Yiyi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Data Intelligence, Department of Computer Science, Key Laboratory of Intelligent Manufacturing Technology of Ministry of Education, College of Engineering, Shantou University, Shantou 515063, China."}], "LastName": "Cai", "ForeName": "Chuipu", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China."}], "LastName": "Liao", "ForeName": "Yanfang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China."}], "LastName": "Dai", "ForeName": "Zhao", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China."}], "LastName": "Fang", "ForeName": "Shuhuan", "Initials": "S"}, {"Identifier": ["0000-0002-6998-5384"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China."}], "LastName": "Fang", "ForeName": "Jiansong", "Initials": "J"}], "GrantList": [{"GrantID": "No. A1-2601-23-414-453Z66", "Agency": "d Open Bidding for Selecting the Best Candidates in Guangzhou University 492 of Chinese Medicine", "Country": ""}, {"GrantID": "(No.2021ZDZX 2001", "Agency": "Special Foundation of Guandong Educational Committe", "Country": ""}, {"GrantID": "2022B1212010012", "Agency": "Guangdong Provincial Key Laboratory of Prescription and Syndrome", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "XH1TI1759C", "NameOfSubstance": "osthol"}, {"RegistryNumber": "X2RN3Q8DNE", "NameOfSubstance": "Galactose"}, {"RegistryNumber": "0", "NameOfSubstance": "Coumarins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Galactose"}, {"QualifierName": [], "DescriptorName": "Neuroinflammatory Diseases"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Cognitive Dysfunction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Coumarins"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Alzheimer Disease"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Alzheimer\u2019s Association 2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2023;19:1598\u20131695. doi: 10.1002/alz.13016.", "ArticleIdList": ["10.1002/alz.13016", "36918389"]}, {"Citation": "Knopman D.S., Amieva H., Petersen R.C., Ch\u00e9telat G., Holtzman D.M., Hyman B.T., Nixon R.A., Jones D.T. Alzheimer disease. Nat. Rev. Dis. Primers. 2021;7:33. doi: 10.1038/s41572-021-00269-y.", "ArticleIdList": ["10.1038/s41572-021-00269-y", "PMC8574196", "33986301"]}, {"Citation": "Cummings J., Lee G., Nahed P., Kambar M., Zhong K., Fonseca J., Taghva K. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement. 2022;8:e12295. doi: 10.1002/trc2.12295.", "ArticleIdList": ["10.1002/trc2.12295", "PMC9066743", "35516416"]}, {"Citation": "Bendlin B.B., Zetterberg H. The iterative process of fluid biomarker development and validation in Alzheimer\u2019s disease. Alzheimers Dement. 2022;14:e12341. doi: 10.1002/dad2.12341.", "ArticleIdList": ["10.1002/dad2.12341", "PMC9274795", "35845265"]}, {"Citation": "Sun M., Sun M., Zhang J. Osthole: An overview of its sources, biological activities, and modification development. Med. Chem. Res. 2021;30:1767\u20131794. doi: 10.1007/s00044-021-02775-w.", "ArticleIdList": ["10.1007/s00044-021-02775-w", "PMC8341555", "34376964"]}, {"Citation": "Zafar S., Sarfraz I., Rasul A., Shah M.A., Hussain G., Zahoor M.K., Shafiq N., Riaz A., Selamoglu Z., Sarker S.D. Osthole: A Multifunctional Natural Compound with Potential Anticancer, Antioxidant and Anti-inflammatory Activities. Mini Rev. Med. Chem. 2021;21:2747\u20132763. doi: 10.2174/1389557520666200709175948.", "ArticleIdList": ["10.2174/1389557520666200709175948", "32646359"]}, {"Citation": "Yao Y., Gao Z., Liang W., Kong L., Jiao Y., Li S., Tao Z., Yan Y., Yang J. Osthole promotes neuronal differentiation and inhibits apoptosis via Wnt/\u03b2-catenin signaling in an Alzheimer\u2019s disease model. Toxicol. Appl. Pharmacol. 2015;289:474\u2013481. doi: 10.1016/j.taap.2015.10.013.", "ArticleIdList": ["10.1016/j.taap.2015.10.013", "26525509"]}, {"Citation": "Dong X., Zhang D., Zhang L., Li W., Meng X. Osthole improves synaptic plasticity in the hippocampus and cognitive function of Alzheimer\u2019s disease rats via regulating glutamate. Neural Regen. Res. 2012;7:2325\u20132332.", "ArticleIdList": ["PMC4268736", "25538756"]}, {"Citation": "Chu Q., Zhu Y., Cao T., Zhang Y., Chang Z., Liu Y., Lu J., Zhang Y. Studies on the Neuroprotection of Osthole on Glutamate-Induced Apoptotic Cells and an Alzheimer\u2019s Disease Mouse Model via Modulation Oxidative Stress. Appl. Biochem. Biotechnol. 2020;190:634\u2013644. doi: 10.1007/s12010-019-03101-2.", "ArticleIdList": ["10.1007/s12010-019-03101-2", "31407160"]}, {"Citation": "Barab\u00e1si A.L., Gulbahce N., Loscalzo J. Network medicine: A network-based approach to human disease. Nat. Rev. Genet. 2011;12:56\u201368. doi: 10.1038/nrg2918.", "ArticleIdList": ["10.1038/nrg2918", "PMC3140052", "21164525"]}, {"Citation": "Jarrell J.T., Gao L., Cohen D.S., Huang X. Network Medicine for Alzheimer\u2019s Disease and Traditional Chinese Medicine. Molecules. 2018;23:1143. doi: 10.3390/molecules23051143.", "ArticleIdList": ["10.3390/molecules23051143", "PMC6099497", "29751596"]}, {"Citation": "Fang J., Pieper A.A., Nussinov R., Lee G., Bekris L., Leverenz J.B., Cummings J., Cheng F. Harnessing endophenotypes and network medicine for Alzheimer\u2019s drug repurposing. Med. Res. Rev. 2020;40:2386\u20132426. doi: 10.1002/med.21709.", "ArticleIdList": ["10.1002/med.21709", "PMC7561446", "32656864"]}, {"Citation": "Fang J., Zhang P., Zhou Y., Chiang C.W., Tan J., Hou Y., Stauffer S., Li L., Pieper A.A., Cummings J., et al. Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer\u2019s disease. Nat. Aging. 2021;1:1175\u20131188. doi: 10.1038/s43587-021-00138-z.", "ArticleIdList": ["10.1038/s43587-021-00138-z", "PMC9097949", "35572351"]}, {"Citation": "Li D., Cai C., Liao Y., Wu Q., Ke H., Guo P., Wang Q., Ding B., Fang J., Fang S. Systems pharmacology approach uncovers the therapeutic mechanism of medicarpin against scopolamine-induced memory loss. Phytomedicine. 2021;91:153662. doi: 10.1016/j.phymed.2021.153662.", "ArticleIdList": ["10.1016/j.phymed.2021.153662", "34333326"]}, {"Citation": "Azman K.F., Zakaria R. D-Galactose-induced accelerated aging model: An overview. Biogerontology. 2019;20:763\u2013782. doi: 10.1007/s10522-019-09837-y.", "ArticleIdList": ["10.1007/s10522-019-09837-y", "31538262"]}, {"Citation": "Chiroma S.M., Mohd Moklas M.A., Mat Taib C.N., Baharuldin M.T.H., Amon Z. d-galactose and aluminium chloride induced rat model with cognitive impairments. Biomed. Pharmacother. 2018;103:1602\u20131608. doi: 10.1016/j.biopha.2018.04.152.", "ArticleIdList": ["10.1016/j.biopha.2018.04.152", "29864948"]}, {"Citation": "Evin G., Barakat A., Masters C.L. BACE: Therapeutic target and potential biomarker for Alzheimer\u2019s disease. Int. J. Biochem. Cell Biol. 2010;42:1923\u20131926. doi: 10.1016/j.biocel.2010.08.017.", "ArticleIdList": ["10.1016/j.biocel.2010.08.017", "20817005"]}, {"Citation": "Singh N., Das B., Zhou J., Hu X., Yan R. Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance. Sci. Adv. 2022;8:eabo3610. doi: 10.1126/sciadv.abo3610.", "ArticleIdList": ["10.1126/sciadv.abo3610", "PMC9299535", "35857844"]}, {"Citation": "D\u2019Amelio M., Cavallucci V., Middei S., Marchetti C., Pacioni S., Ferri A., Diamantini A., De Zio D., Carrara P., Battistini L., et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer\u2019s disease. Nat. Neurosci. 2011;14:69\u201376. doi: 10.1038/nn.2709.", "ArticleIdList": ["10.1038/nn.2709", "21151119"]}, {"Citation": "Liu S.L., Wang C., Jiang T., Tan L., Xing A., Yu J.T. The Role of Cdk5 in Alzheimer\u2019s Disease. Mol. Neurobiol. 2016;53:4328\u20134342. doi: 10.1007/s12035-015-9369-x.", "ArticleIdList": ["10.1007/s12035-015-9369-x", "26227906"]}, {"Citation": "Zhou R., Ji B., Kong Y., Qin L., Ren W., Guan Y., Ni R. PET Imaging of Neuroinflammation in Alzheimer\u2019s Disease. Front. Immunol. 2021;12:739130. doi: 10.3389/fimmu.2021.739130.", "ArticleIdList": ["10.3389/fimmu.2021.739130", "PMC8481830", "34603323"]}, {"Citation": "Fricker M., Tolkovsky A.M., Borutaite V., Coleman M., Brown G.C. Neuronal Cell Death. Physiol. Rev. 2018;98:813\u2013880. doi: 10.1152/physrev.00011.2017.", "ArticleIdList": ["10.1152/physrev.00011.2017", "PMC5966715", "29488822"]}, {"Citation": "Uddin M.S., Yu W.S., Lim L.W. Exploring ER stress response in cellular aging and neuroinflammation in Alzheimer\u2019s disease. Ageing Res. Rev. 2021;70:101417. doi: 10.1016/j.arr.2021.101417.", "ArticleIdList": ["10.1016/j.arr.2021.101417", "34339860"]}, {"Citation": "Maino B., Paparone S., Severini C., Ciotti M.T., D\u2019Agata V., Calissano P., Cavallaro S. Drug target identification at the crossroad of neuronal apoptosis and survival. Expert. Opin. Drug Discov. 2017;12:249\u2013259. doi: 10.1080/17460441.2017.1280023.", "ArticleIdList": ["10.1080/17460441.2017.1280023", "28067072"]}, {"Citation": "Obulesu M., Lakshmi M.J. Apoptosis in Alzheimer\u2019s disease: An understanding of the physiology, pathology and therapeutic avenues. Neurochem. Res. 2014;39:2301\u20132312. doi: 10.1007/s11064-014-1454-4.", "ArticleIdList": ["10.1007/s11064-014-1454-4", "25322820"]}, {"Citation": "Kumari S., Dhapola R., Reddy D.H. Apoptosis in Alzheimer\u2019s disease: Insight into the signaling pathways and therapeutic avenues. Apoptosis. 2023;28:943\u2013957. doi: 10.1007/s10495-023-01848-y.", "ArticleIdList": ["10.1007/s10495-023-01848-y", "37186274"]}, {"Citation": "Kumar M., Bansal N. Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer\u2019s Disease. Mol. Neurobiol. 2022;59:354\u2013385. doi: 10.1007/s12035-021-02611-7.", "ArticleIdList": ["10.1007/s12035-021-02611-7", "34699027"]}, {"Citation": "Saahene R.O., Agbo E., Barnes P., Yahaya E.S., Amoani B., Nuvor S.V., Okyere P. A Review: Mechanism of Phyllanthus urinaria in Cancers-NF-kappaB, P13K/AKT, and MAPKs Signaling Activation. Evid. Based Complement. Altern. Med. 2021;2021:4514342. doi: 10.1155/2021/4514342.", "ArticleIdList": ["10.1155/2021/4514342", "PMC8413045", "34484390"]}, {"Citation": "Leng F., Edison P. Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here? Nat. Rev. Neurol. 2021;17:157\u2013172. doi: 10.1038/s41582-020-00435-y.", "ArticleIdList": ["10.1038/s41582-020-00435-y", "33318676"]}, {"Citation": "Dhapola R., Hota S.S., Sarma P., Bhattacharyya A., Medhi B., Reddy D.H. Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology. 2021;29:1669\u20131681. doi: 10.1007/s10787-021-00889-6.", "ArticleIdList": ["10.1007/s10787-021-00889-6", "PMC8608577", "34813026"]}, {"Citation": "Fakhoury M. Microglia and Astrocytes in Alzheimer\u2019s Disease: Implications for Therapy. Curr. Neuropharmacol. 2018;16:508\u2013518. doi: 10.2174/1570159X15666170720095240.", "ArticleIdList": ["10.2174/1570159X15666170720095240", "PMC5997862", "28730967"]}, {"Citation": "Ju Hwang C., Choi D.Y., Park M.H., Hong J.T. NF-kappaB as a Key Mediator of Brain Inflammation in Alzheimer\u2019s Disease. CNS Neurol. Disord. Drug Targets. 2019;18:3\u201310. doi: 10.2174/1871527316666170807130011.", "ArticleIdList": ["10.2174/1871527316666170807130011", "28782486"]}, {"Citation": "Shi Z.M., Han Y.W., Han X.H., Zhang K., Chang Y.N., Hu Z.M., Qi H.X., Ting C., Zhen Z., Hong W. Upstream regulators and downstream effectors of NF-\u03baB in Alzheimer\u2019s disease. J. Neurol. Sci. 2016;366:127\u2013134. doi: 10.1016/j.jns.2016.05.022.", "ArticleIdList": ["10.1016/j.jns.2016.05.022", "27288790"]}, {"Citation": "Uddin M.S., Tewari D., Sharma G., Kabir M.T., Barreto G.E., Bin-Jumah M.N., Perveen A., Abdel-Daim M.M., Ashraf G.M. Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer\u2019s Disease. Mol. Neurobiol. 2020;57:2902\u20132919. doi: 10.1007/s12035-020-01929-y.", "ArticleIdList": ["10.1007/s12035-020-01929-y", "32430843"]}, {"Citation": "Hashimoto S., Saido T.C. Critical review: Involvement of endoplasmic reticulum stress in the aetiology of Alzheimer\u2019s disease. Open Biol. 2018;8:180024. doi: 10.1098/rsob.180024.", "ArticleIdList": ["10.1098/rsob.180024", "PMC5936719", "29695619"]}, {"Citation": "Aisen P.S., Cummings J., Jack C.R., Jr., Morris J.C., Sperling R., Fr\u00f6lich L., Jones R.W., Dowsett S.A., Matthews B.R., Raskin J., et al. On the path to 2025: Understanding the Alzheimer\u2019s disease continuum. Alzheimers Res. Ther. 2017;9:60. doi: 10.1186/s13195-017-0283-5.", "ArticleIdList": ["10.1186/s13195-017-0283-5", "PMC5549378", "28793924"]}, {"Citation": "Guzman-Martinez L., Calf\u00edo C., Farias G.A., Vilches C., Prieto R., Maccioni R.B. New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer\u2019s Disease. J. Alzheimers Dis. 2021;82((Suppl. S1)):S51\u2013S63. doi: 10.3233/JAD-201059.", "ArticleIdList": ["10.3233/JAD-201059", "33523002"]}, {"Citation": "Maccioni R.B., Calf\u00edo C., Gonz\u00e1lez A., L\u00fcttges V. Novel Nutraceutical Compounds in Alzheimer Prevention. Biomolecules. 2022;12:249. doi: 10.3390/biom12020249.", "ArticleIdList": ["10.3390/biom12020249", "PMC8961630", "35204750"]}, {"Citation": "Banji O.J., Banji D., Ch K. Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brain. Food Chem. Toxicol. 2014;74:51\u201359. doi: 10.1016/j.fct.2014.08.020.", "ArticleIdList": ["10.1016/j.fct.2014.08.020", "25217884"]}, {"Citation": "Cao P., Zhang J., Huang Y., Fang Y., Lyu J., Shen Y. The age-related changes and differences in energy metabolism and glutamate-glutamine recycling in the d-gal-induced and naturally occurring senescent astrocytes in vitro. Exp. Gerontol. 2019;118:9\u201318. doi: 10.1016/j.exger.2018.12.018.", "ArticleIdList": ["10.1016/j.exger.2018.12.018", "30610899"]}, {"Citation": "Chi H., Chang H.Y., Sang T.K. Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases. Int. J. Mol. Sci. 2018;19:3082. doi: 10.3390/ijms19103082.", "ArticleIdList": ["10.3390/ijms19103082", "PMC6213751", "30304824"]}, {"Citation": "Moujalled D., Strasser A., Liddell J.R. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28:2029\u20132044. doi: 10.1038/s41418-021-00814-y.", "ArticleIdList": ["10.1038/s41418-021-00814-y", "PMC8257776", "34099897"]}, {"Citation": "Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J. Neuroinflamm. 2022;19:206. doi: 10.1186/s12974-022-02565-0.", "ArticleIdList": ["10.1186/s12974-022-02565-0", "PMC9382837", "35978311"]}, {"Citation": "Huang Y., Fang J., Lu W., Wang Z., Wang Q., Hou Y., Jiang X., Reizes O., Lathia J., Nussinov R., et al. A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling. Cell Chem. Biol. 2019;26:1143\u20131158.e6. doi: 10.1016/j.chembiol.2019.05.004.", "ArticleIdList": ["10.1016/j.chembiol.2019.05.004", "PMC6697584", "31178408"]}, {"Citation": "Yan D., Zheng G., Wang C., Chen Z., Mao T., Gao J., Yan Y., Chen X., Ji X., Yu J., et al. HIT 2.0: An enhanced platform for Herbal Ingredients\u2019 Targets. Nucleic Acids Res. 2021;50:D1238\u2013D1243. doi: 10.1093/nar/gkab1011.", "ArticleIdList": ["10.1093/nar/gkab1011", "PMC8728248", "34986599"]}, {"Citation": "Cheng F., Lu W., Liu C., Fang J., Hou Y., Handy D.E., Wang R., Zhao Y., Yang Y., Huang J., et al. A genome-wide positioning systems network algorithm for in silico drug repurposing. Nat. Commun. 2019;10:3476. doi: 10.1038/s41467-019-10744-6.", "ArticleIdList": ["10.1038/s41467-019-10744-6", "PMC6677722", "31375661"]}, {"Citation": "Fang J., Zhang P., Wang Q., Chiang C.W., Zhou Y., Hou Y., Xu J., Chen R., Zhang B., Lewis S.J., et al. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer\u2019s disease. Alzheimers Res. Ther. 2022;14:7. doi: 10.1186/s13195-021-00951-z.", "ArticleIdList": ["10.1186/s13195-021-00951-z", "PMC8751379", "35012639"]}, {"Citation": "Wu Q., Fan X., Hong H., Gu Y., Liu Z., Fang S., Wang Q., Cai C., Fang J. Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective. Food Chem. Toxicol. 2020;145:111767. doi: 10.1016/j.fct.2020.111767.", "ArticleIdList": ["10.1016/j.fct.2020.111767", "PMC7505223", "32971210"]}]}], "History": [{"Year": "2023", "Month": "11", "Day": "11"}, {"Year": "2023", "Month": "12", "Day": "7"}, {"Year": "2023", "Month": "12", "Day": "12"}, {"Year": "2024", "Month": "1", "Day": "12", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "11", "Hour": "7", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "11", "Hour": "1", "Minute": "12"}, {"Year": "2023", "Month": "12", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["38202603", "PMC10779601", "10.3390/molecules29010021", "molecules29010021"]}}]}